Filter
5328
Filtered Results: 5328
Text search:
National
Centre
for
Disease
Control
Featured
Recommendations
524
New Publications
1500
Language
Document type
No document type
3036
Studies & Reports
882
Guidelines
722
Manuals
283
Strategic & Response Plan
196
Training Material
67
Fact sheets
63
Situation Updates
49
Resource Platforms
15
Infographics
7
Brochures
6
Online Courses
2
Countries / Regions
India
352
Global
190
Kenya
147
Western and Central Europe
146
Sierra Leone
134
Nigeria
112
Nepal
112
South Africa
107
Uganda
104
Liberia
89
Africa
83
Congo, Democratic Republic of
77
Zambia
77
Tanzania
77
Ethiopia
75
Malawi
73
Bangladesh
71
Rwanda
68
Ghana
66
Myanmar / Burma
65
Ukraine
64
Eastern Europe
50
Guinea
49
Syria
49
Namibia
48
Senegal
46
Latin America and the Carribbean
43
West and Central Africa
40
Mozambique
38
Asia
38
South Sudan
36
Burkina Faso
33
Zimbabwe
33
Haiti
31
South–East Asia Region
31
Lesotho
30
East and Southern Africa
30
Cambodia
29
Russia
28
Eastern Europe and Central Asia
27
Cameroon
26
Germany
26
Philippines
22
Middle East and North Africa
22
Madagascar
20
Benin
19
Botswana
18
Yemen
18
Mali
16
Pakistan
16
Afghanistan
16
Indonesia
16
Central African Republic
16
Brazil
16
Eswatini/ Swaziland
14
Western Pacific Region
14
Tajikistan
13
Angola
12
Moldova
12
Somalia
11
Thailand
11
Albania
11
Sudan
10
Côte d’Ivoire / Ivory Coast
9
Togo
9
Jordan
9
Niger
7
Iraq
7
Lebanon
7
China
7
Colombia
7
Chad
6
Papua New Guinea
6
Argentina
6
North Macedonia
6
Burundi
6
Ecuador
6
Paraguay
6
Venezuela
6
Laos
6
Georgia
6
Vietnam
6
Guinea-Bissau
5
Libya
5
Poland
5
Southern Africa
5
Romania
5
Hungary
4
Sri Lanka
4
Palestine
4
Armenia
4
Kyrgyzstan
4
Kazakhstan
4
Turkmenistan
4
France
4
USA
3
Saudi Arabia
3
Turkey
3
Gambia
3
Peru
3
El Salvador
3
Chile
3
Congo-Brazzaville
3
Timor Leste/ East Timor
3
Uzbekistan
3
Spain
3
Belarus
3
Mauritania
2
Mexico
2
Fiji
2
Italy
2
Canada
2
Bulgaria
2
Estonia
2
Slovakia
2
Iran
2
North America
2
Belgium
2
Mauritius
2
United Kingdom
2
Portugal
2
Bosnia and Herzegovina
2
Morocco
1
Malaysia
1
Ireland
1
Singapore
1
Vanuatu
1
Dominican Republic
1
Serbia
1
Honduras
1
Bolivia
1
Greece
1
Other region
1
Solomon Islands
1
Bhutan
1
North Korea
1
Djibouti
1
Mongolia
1
Qatar
1
Lithuania
1
Gabon
1
Denmark
1
Maldives
1
Tunisia
1
Azerbaijan
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
2069
Clinical Guidelines
459
Public Health
292
Women & Child Health
211
Key Resources
208
Capacity Building
81
Pharmacy & Technologies
71
Toolboxes
COVID-19
478
HIV
394
TB
366
Mental Health
339
Ebola
239
Rapid Response
238
AMR
194
Planetary Health
191
NTDs
136
Caregiver
132
Disability
121
Conflict
120
Pharmacy
95
NCDs
89
Refugee
84
Global Health Education
76
Natural Hazards
56
Zika
49
Polio
38
Health Financing Toolbox
38
Cholera
33
Specific Hazards
25
Social Ethics
10
South Sudan
1
Typhoon
1
Health Financing
1
European Union Standards for Tuberculosis Care 2017 Estonian Version
European Union Standards for Tuberculosis Care 2017 Update (Romanian Version)
Social distancing is an action taken to minimise contact with other individuals; social distancing measures comprise one category of non-pharmaceutical countermeasures (NPCs)1 aimed at reducing disease transmission and thereby also reducing pressure...
23 Dec 2020. The aim of this document is to provide an update on the knowledge surrounding the role of children in the transmission of SARS-CoV-2 and the role of schools in the COVID-19 pandemic, based on the experience in the EU from August–December, 2020. This document also addresses transmissio...
Cases of monkeypox (MPX) acquired in the EU have recently been reported in nine EU Member States (Austria, Belgium, France, Germany, Italy, Portugal, Spain, Sweden, and the Netherlands).
Monkeypox (MPX) does not spread easily between people. Human-to-human transmission occurs through close contact ...
The second ECDC/EFSA/EMA joint report on the integrated analysis of antimicrobial consumption (AMC) and antimicrobial resistance (AMR) in bacteria from humans and food-producing animals addressed data obtained by the Agencies’ EU-wide surveillance networks ... 2013–2015. AMC in both sectors, expressed in mg/kg of estimated biomass, were compared at country and European level. Substantial variations between countries were observed in both sectors. Estimated data on AMC for pigs and poultry were used for the first time. Univariate and multivariate analyses were applied to study associations between AMC and AMR. In 2014, the average AMC was higher in animals (152 mg/kg) than in humans (124 mg/kg), but the opposite applied to the median AMC (67 and 118 mg/kg, respectively). In 18 of 28 countries, AMC was lower in animals than in humans. Univariate analysis showed statistically-significant (p < 0.05) associations between AMC and AMR for fluoroquinolones and Escherichia coli in both sectors, for 3rd- and 4th-generation cephalosporins and E. coli in humans, and tetracyclines and polymyxins and E. coli in animals. In humans, there was a statistically-significant association between AMC and AMR for carbapenems and polymyxins in Klebsiella pneumoniae. Consumption of macrolides in animals was significantly associated with macrolide resistance in Campylobacter coli in animals and humans. Multivariate analyses provided a unique approach to assess the contributions of AMC in humans and animals and AMR in bacteria from animals to AMR in bacteria from humans. Multivariate analyses demonstrated that 3rd- and 4th-generation cephalosporin and fluoroquinolone resistance in E. coli from humans was associated with corresponding AMC in humans, whereas resistance to fluoroquinolones in Salmonella spp. and Campylobacter spp. from humans was related to consumption of fluoroquinolones in animals. These results suggest that from a ‘One-health’ perspective, there is potential in both sectors to further develop prudent use of antimicrobials and thereby reduce AMR.
This technical guidance aims to provide guidelines to laboratories and relevant stakeholders in the European Union (EU), European Economic Area (EEA) and other countries in the WHO European region in making decisions on establishing sequencing capacities and capabilities, in making decisions on whic...
This report of the EFSA and ECDC presents the results of zoonoses monitoring activities carried out in 2020 in 27 EU Member States (MS) and nine non-MS. Key statistics on zoonoses and zoonotic agents in humans, food, animals and feed are provided and interpreted historically.
This report provides an overview of the main findings of the 2019–2020 harmonised AMR monitoring in the main food-producing animal populations monitored, in carcase/meat samples and in humans. Where available, monitoring data obtained from pigs, calves, broilers, laying hens and turkeys, as well a...
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Division of Tuberculosis Elimination.
This report presents the main characteristics of Ebola emergency preparedness in three EU Member States. Findings are organised in five sections: preparedness planning, organisational structures, recourses and capacities, intersectoral and cross-border collaboration, and country-specific findings
A GUIDE FOR HEALTH WORKERS AND AUTHORITIES IN NIGERIA
A GUIDE FOR HEALTH WORKERS AND AUTHORITIES IN NIGERIA
This manual presents a compelling case for action on carbapenem-resistant organisms (CROs) and describes the linkages between the prevention and control of CROs and the Global Action Plan on Antimic...
This toolkit for integrated vector management (IVM) is designed to help national and regional programme managers coordinate across sectors to design and run large IVM programmes.
The toolkit pr...
The toolkit pr...
Over the past 20 years, the Global Initiative for Asthma (GINA) has regularly published and annually updated a global strategy for asthma management and prevention that has formed the basis ... many national guidelines. However, uptake of existing guidelines is poor. A major revision of the GINA report was published in 2014, and updated in 2015, reflecting an evolving understanding of heterogeneous airways disease, a broader evidence base, increasing interest in targeted treatment, and evidence about effective implementation approaches. During development of the report, the clinical utility of recommendations and strategies for their practical implementation were considered in parallel with the scientific evidence.
The National Strategic Plan for HIV/AIDS and STIs 2017-2024 spells out the objectives and targets that we have jointly committed to achieve. The plan describes the strategies and activities that wil...
